Accustem Sciences ACUT
OTC ACUT
$0.12 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Accustem Sciences (ACUT) EBIT Margin (2026)

Updated

Accustem Sciences' EBIT Margin came in at -256.68% for Q2 2026.

Analysis

Accustem Sciences (ACUT) EBIT Margin (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 HCA Healthcare 94.29 Bn 93.74 Bn - 15.29%
2 Natera 59.14 Bn 54.82 Bn 485.19 Mn -10.07%
3 Quest Diagnostics 26.23 Bn 24.66 Bn 1.03 Bn 15.08%
4 Labcorp Holdings 25.04 Bn 22.81 Bn 1.11 Bn 12.10%
5 Guardant Health 23.69 Bn 19.76 Bn 219.03 Mn -38.55%
6 Tenet Healthcare 20.77 Bn 11.92 Bn - 26.67%
7 Tempus AI 14.91 Bn 11.94 Bn 246.50 Mn -19.85%
8 Encompass Health 12.24 Bn 12.70 Bn - 18.43%
9 Davita 11.39 Bn 10.15 Bn 1.16 Bn 16.29%
10 Accustem Sciences 1.93 Mn 1.88 Mn - -256.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -256.68%
API Access

Accustem Sciences EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ACUT&period=max&api_key=YOUR_API_KEY